Medical Oncologist
Metastatic breast cancer
First-line treatment for hormone-positive metastatic breast cancer
For most people with hormone-positive, HER2-negative metastatic breast cancer, the first treatment is hormone therapy with a CDK4/6 inhibitor tablet, plus ovarian suppression before menopause. Chemotherapy is kept for fast-growing cancer. This page explains the options and daily life.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is first-line treatment for hormone-positive metastatic breast cancer?
- The parts of first-line treatment
- Which first-line option fits which situation, in general terms
- The vocabulary, in plain language
- Honest expectations on first-line treatment
- What to expect when you start treatment
- Living well on long-term hormone and targeted treatment
- Questions to ask about first-line treatment
- First-line treatment for younger women
- What people assume about first-line treatment
- Common questions about first-line treatment
The short answer
What is first-line treatment for hormone-positive metastatic breast cancer?
For most people with hormone receptor positive, HER2-negative metastatic breast cancer, the recommended first treatment is hormone therapy combined with a targeted tablet called a CDK4/6 inhibitor. Hormone therapy lowers or blocks oestrogen, which this type of cancer uses to grow. The most commonly used hormone medicines in this setting are aromatase inhibitors, or a medicine that blocks and breaks down the oestrogen receptor, particularly when cancer returned during or soon after earlier hormone therapy. CDK4/6 inhibitors slow the division of cancer cells, and adding them to hormone therapy has been shown in large trials to keep cancer under control considerably longer, and for some combinations to help people live longer, compared with hormone therapy alone. Women who have not reached menopause also receive treatment to switch off the ovaries. Chemotherapy is usually reserved for first-line use when cancer is growing very quickly or vital organs such as the liver or lungs are seriously affected and a rapid response is needed. This combination is taken at home as tablets and injections, allowing many people to continue their daily lives.
Tests before starting
A biopsy of a metastatic area, where possible, confirms receptor status. Blood counts, liver tests and a heart tracing are usually checked before starting a CDK4/6 inhibitor.
How long treatment continues
Treatment continues as long as it controls the cancer and side effects are manageable, which for many people is a year or more, and for some several years.
Genetic testing
Testing the cancer or blood for certain gene changes may be advised now or later, as results can guide the next line.
This page gives general information only. Your oncologist will recommend the treatment that suits you.The building blocks
The parts of first-line treatment
Most people receive a combination rather than a single medicine.
Hormone therapy
An aromatase inhibitor tablet or an oestrogen receptor blocker injection to starve the cancer of oestrogen signals.
CDK4/6 inhibitor
A daily tablet, often taken in cycles, that slows cancer cell division.
Blood counts are checked regularly.Ovarian suppression
Monthly or three-monthly injections for women before menopause, or surgery to remove the ovaries.
Bone protection
Bone-strengthening medicines when cancer has spread to bone.
Supportive care also includes
- Calcium and vitamin D when advised
- Dental checks before bone medicines
- Pain and symptom control
Choosing the approach
Which first-line option fits which situation, in general terms
Situation
Usual first-line approach
Most people, cancer not growing rapidly
Hormone therapy plus a CDK4/6 inhibitor
Before menopause
The same, with ovarian suppression added
Relapse during or soon after aromatase inhibitor
An oestrogen receptor blocker with a CDK4/6 inhibitor is often preferred
Organs under serious strain
Chemotherapy may be used first for a faster response
Frail or unable to take a CDK4/6 inhibitor
Hormone therapy alone may be considered
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- Hormone receptor positive
- Cancer that uses oestrogen or progesterone to grow.
- Aromatase inhibitor
- A tablet that lowers oestrogen after menopause.
- SERD
- A medicine that blocks and breaks down the oestrogen receptor.
- CDK4/6 inhibitor
- A targeted tablet that slows cancer cell division.
- Ovarian function suppression
- Switching off the ovaries with injections or surgery.
- Progression-free survival
- How long cancer is controlled before it grows.
Being straight with you
Honest expectations on first-line treatment
First-line hormone therapy with a CDK4/6 inhibitor is one of the most effective treatments in metastatic breast cancer, but it has side effects, costs and limits that are worth understanding.
Side effects are common but manageable
Low white cell counts, tiredness, nausea, loose motions, hair thinning and joint aches are common. Dose reductions or short breaks often help without reducing benefit.
Regular monitoring is needed
Blood tests are done frequently in the first months, and some medicines need heart and liver checks.
Cost and access
Targeted tablets can be expensive. Ask about generic versions, insurance, government schemes and patient access programmes.
Treatment eventually stops working
For most people the cancer eventually becomes resistant, and the next line is planned then.
What this page cannot tell you
It cannot choose your treatment. Ask your oncologist which combination suits you.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
The first months
What to expect when you start treatment
The first few months involve more frequent visits while your team makes sure the treatment suits you.
Taking tablets correctly
Take tablets at the same time each day as prescribed. Some are taken for three weeks followed by a week off. Use a calendar or phone reminder, and do not double up if you miss a dose.
Blood tests
Blood counts are usually checked every two to four weeks at first, then less often. Low counts often recover with a short pause.
Medicine interactions
Some foods, herbal products and medicines can affect CDK4/6 inhibitor levels. Tell your team about everything you take, and ask before starting anything new.
First scan
Scans are usually repeated after about three months to check response.
When to call
Call promptly for fever, severe loose motions, breathlessness or chest pain.
Daily life
Living well on long-term hormone and targeted treatment
Many people on first-line treatment continue working, caring for family and travelling.
Managing tiredness
Regular gentle exercise, good sleep habits and pacing activities help energy levels.
Joint aches
Stretching, walking and pain relief approved by your team ease aches from hormone therapy.
Menopause symptoms
Hot flushes, vaginal dryness and mood changes are common. Non-hormonal treatments can help, so mention them.
Bone health
Weight-bearing exercise, calcium and vitamin D when advised, and bone medicines protect bones.
Emotional support
Living with long-term treatment can be tiring emotionally. Support groups and counselling help.
At your appointment
Questions to ask about first-line treatment
Written questions help you understand your plan and make decisions.
About the choice
Why is this combination recommended for me? Would chemotherapy be better at this stage, and why or why not?
About practical matters
How often are blood tests and scans? What does it cost, and are there support programmes?
About the future
Should genetic testing of my cancer be done now? What are the likely options if this stops working?
Before menopause
First-line treatment for younger women
Hormone-positive metastatic breast cancer in women who still have periods is treated in the same way as after menopause, with one important addition: the ovaries must be switched off, because they are the main source of oestrogen.
Switching off the ovaries
This is usually done with injections given every month or every three months. Some women choose surgery to remove the ovaries, which avoids repeated injections but is permanent.
Menopause symptoms
Hot flushes, sleep problems, vaginal dryness and mood changes can start suddenly and feel stronger than a natural menopause. Tell your team, as non-hormonal treatments and practical changes can help.
Contraception and fertility
Pregnancy should be avoided during treatment, and hormonal contraception is not suitable. Ask about non-hormonal methods, and discuss any fertility wishes openly with your team.
Family and work life
Younger women often balance treatment with children, careers and caring for parents. Counsellors and support groups for younger women can help.
Commonly believed
What people assume about first-line treatment
Chemotherapy is always stronger and should come first.
For most hormone-positive cancers, hormone therapy with targeted tablets works as well or better, with fewer side effects.
Tablets cannot be as effective as drips.
Oral targeted treatments are among the most effective options.
A dose reduction means treatment will not work.
Studies show dose reductions usually do not reduce benefit.
Young women cannot have this treatment.
Women before menopause receive it with ovarian suppression.
Questions we are asked
Common questions about first-line treatment
Will I lose my hair?
Hair thinning can occur with some CDK4/6 inhibitors, but complete hair loss is uncommon.
Can I work during treatment?
Many people do. Discuss flexible arrangements if tiredness is a problem.
What if my white cell count is low?
Your team may pause or reduce the dose. Report fever promptly.
Can I take herbal supplements?
Ask first, as some interact with targeted tablets.
How long will I take this treatment?
As long as it controls the cancer and side effects are manageable.
Is chemotherapy ever used first?
Yes, when organs are under serious strain or cancer is growing very fast.
Can I get a second opinion?
Yes. Bring pathology, scans and treatment history.
Who helps with cost?
Financial counsellors can explain schemes and access programmes.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- European Society for Medical Oncology — Metastatic breast cancer clinical practice guideline
- American Society of Clinical Oncology — Endocrine treatment and targeted therapy for hormone receptor-positive metastatic breast cancer
- National Cancer Institute — Hormone therapy for breast cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.